Business Standard

3 US firms working with Indian cos for mass production of vaccines: Com Min

Three US-based companies are currently engaged with their Indian counterparts for mass production of Covid-19 vaccines in India, the commerce ministry said

AstraZeneca wasn't the obvious choice to partner up with Oxford when scientists there started developing a coronavirus shot. Photographer: Mikael Sjoberg/Bloomberg

Representational image of a Covid-19 vaccine

Press Trust of India New Delhi
Three US-based companies are currently engaged with their Indian counterparts for mass production of COVID-19 vaccines in India, the commerce ministry said on Wednesday.
Without giving more details, the ministry said COVID-19 has led to increased trade and cooperation between India and the US.
"Three USA companies are currently engaged with their Indian counterparts for mass production of COVID-19 vaccines in India," it said while listing major highlights of the Department of Commerce during 2020.
It also said the proposed free trade agreement between India and Mauritius is near finalisation as negotiations for trade in goods and services have been completed.
In a free trade agreement, two trading partners cut or eliminate duties on majority of goods traded between them.
"India-Mauritius Comprehensive Economic Cooperation and Partnership Agreement (CECPA) negotiations for trade in goods and trade in services, have been completed. The agreement is near finalisation," it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 30 2020 | 7:37 PM IST

Explore News